Skip to content

industry news

A Protein-Based Gel May One Day Help Rebuild Your Tooth Enamel Without Fluoride

Researchers at the University of Nottingham have published a study on a fluoride-free gel that uses engineered proteins to coax your saliva's own minerals into regrowing damaged tooth enamel — and human trials are now underway.

Tooth enamel is one of the few tissues in the body that cannot repair itself once it is lost.

Enamel degradation is usually irreversible and contributes to dental problems in nearly half the world's population.

That long-standing limitation may eventually change.

Scientists at the University of Nottingham have developed a fluoride-free gel that regenerated damaged tooth enamel in laboratory testing, with their study published in Nature Communications in July 2026.

Unlike conventional fluoride products, the new gel contains no fluoride. Instead, it is made from proteins designed to reproduce important functions of the natural proteins involved in enamel development during infancy. After the gel is placed on a tooth, it forms a thin but durable coating that penetrates the tooth's surface and fills small cracks, pores, and other damaged areas.

Applied like a standard fluoride treatment, it draws calcium and phosphate from the patient's own saliva to grow a new mineral layer that closely matches healthy enamel in structure and strength.

The researchers note meaningful limits: the regenerated layer is quite thin compared to natural enamel on a full molar, so the gel is designed to target early erosion, white-spot lesions, and sensitivity — not deep cavities that require fillings or crowns.

Current treatments such as fluoride varnishes and remineralization solutions can only alleviate symptoms of tooth decay, whereas the developers of this material say it has potential for more effective and longer-lasting treatments that are both preventive and restorative.

In mid-2026, human clinical trials began for the gel, commercialized through a spin-off company called Mintech-Bio.

The researchers have set a goal of launching an initial commercial product as early as 2027, subject to further testing and regulatory approval.

As with any early-stage dental technology, results from those human trials will be the real test of whether what works in the laboratory translates into a reliable chairside treatment.

Source: ScienceDaily / Nature Communications

Published 8/2/2026

← Back to Latest